Bismuth nitrate-induced novel nitration of estradiol: An entry to new anticancer agents
Direct nitration of estradiol was carried out using metal nitrates on solid surfaces under mild condition, and a combination of bismuth nitrate pentahydrate impregnated KSF clay was found to be the best reagent to synthesize 2- and 4-nitroestradiol effectively. Furthermore, various basic side chains...
Gespeichert in:
Veröffentlicht in: | European journal of medicinal chemistry 2014-07, Vol.82, p.574-583 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Direct nitration of estradiol was carried out using metal nitrates on solid surfaces under mild condition, and a combination of bismuth nitrate pentahydrate impregnated KSF clay was found to be the best reagent to synthesize 2- and 4-nitroestradiol effectively. Furthermore, various basic side chains were introduced, through O-linker at C-3, to these nitroestradiols. The ability of these derivatives to cause cytotoxicity in Estrogen Receptor (ER)-positive and ER-negative breast cancer cell lines, as well as cancer cell lines of other origins, was examined. Qualitative structure activity relationship (SAR) has also been studied. We found that a basic side chain containing either a piperidine or morpholine ring, when conjugated to 2-nitroestradiol, was particularly effective at causing cytotoxicity in each of the cancer cell lines examined. Surprisingly, this effective cytotoxicity was even seen in ER-negative breast cancer cells.
[Display omitted]
•An ecofriendly direct procedure for the nitration of estradiol is developed.•Carbon linkers on the oxygen at C-3 with basic terminal moieties are introduced.•Compounds 3 and 4 are cytotoxic for HepG2, Hepa1-6, Hep3B, HeLa and HT-29 cells.•Compound 3 is more potent than 4-HT for both ER-positive and ER-negative cells.•Compound 3 circumvented P-gp mediated drug resistance in ovarian cancer cells. |
---|---|
ISSN: | 0223-5234 1768-3254 |
DOI: | 10.1016/j.ejmech.2014.06.010 |